Glioblastoma: Part I. Current state of affairs
Although uncommon, "brain cancer" is one of the most feared diseases that afflict human beings. While still regarded as one of the most deadly forms of primary brain neoplasm, recent advances in the treatment of glioblastoma (GBM) have offered new hope for patients, families, and clinician...
Gespeichert in:
| Veröffentlicht in: | Missouri medicine 2011-05, Vol.108 (3), p.187-194 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 194 |
|---|---|
| container_issue | 3 |
| container_start_page | 187 |
| container_title | Missouri medicine |
| container_volume | 108 |
| creator | Salacz, Michael E Watson, Kenneth R Schomas, David A |
| description | Although uncommon, "brain cancer" is one of the most feared diseases that afflict human beings. While still regarded as one of the most deadly forms of primary brain neoplasm, recent advances in the treatment of glioblastoma (GBM) have offered new hope for patients, families, and clinicians. In the first part of this two-part review, we will focus on the multidisciplinary advances that have established the current treatment approach in the management of GBM. In the second part of this review, ongoing research will be presented including current clinical trials as well as some of the newer technologies that are forming the promise of the future. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6188294</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>875720966</sourcerecordid><originalsourceid>FETCH-LOGICAL-p180t-8b1b74b2eaec1ddeaf74e49552d297aef1d3308fc7e03368fca70ff5ddadfa283</originalsourceid><addsrcrecordid>eNpVkMFKxDAQhnNQ3HX1FaQ3T13SpE1SD4IUXRcW9KDnMG0mGmmbNUkF396Cq-hpfpif7xvmiCwpZSIXgtEFOY3xjVJeK85OyIIVkgsq6yVZb3rn2x5i8gNcZY8QUrZdZ80UAo4piwkSZt5mYC24EM_IsYU-4vlhrsjz3e1Tc5_vHjbb5maX7wtFU67aopVlyxCwK4xBsLLEsq4qZlgtAW1hOKfKdhIp52IOIKm1lTFgLDDFV-T6m7uf2gFNN98SoNf74AYIn9qD0_83o3vVL_5Di0IpVpcz4PIACP59wpj04GKHfQ8j-ilqJSvJaC3E3Lz4q_p1_PyIfwFeYmMa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>875720966</pqid></control><display><type>article</type><title>Glioblastoma: Part I. Current state of affairs</title><source>MEDLINE</source><source>PubMed Central</source><creator>Salacz, Michael E ; Watson, Kenneth R ; Schomas, David A</creator><creatorcontrib>Salacz, Michael E ; Watson, Kenneth R ; Schomas, David A</creatorcontrib><description>Although uncommon, "brain cancer" is one of the most feared diseases that afflict human beings. While still regarded as one of the most deadly forms of primary brain neoplasm, recent advances in the treatment of glioblastoma (GBM) have offered new hope for patients, families, and clinicians. In the first part of this two-part review, we will focus on the multidisciplinary advances that have established the current treatment approach in the management of GBM. In the second part of this review, ongoing research will be presented including current clinical trials as well as some of the newer technologies that are forming the promise of the future.</description><identifier>ISSN: 0026-6620</identifier><identifier>PMID: 21736079</identifier><language>eng</language><publisher>United States: Journal of the Missouri State Medical Association</publisher><subject>Additional Scientific ; Brain Neoplasms - diagnosis ; Brain Neoplasms - mortality ; Brain Neoplasms - surgery ; Brain Neoplasms - therapy ; Chemotherapy, Adjuvant ; Clinical Trials as Topic ; Combined Modality Therapy - methods ; Glioblastoma - diagnosis ; Glioblastoma - mortality ; Glioblastoma - surgery ; Glioblastoma - therapy ; Humans ; Meta-Analysis as Topic ; Neoplasm Staging ; Radiotherapy, Adjuvant ; Survival Rate ; Treatment Outcome ; United States - epidemiology</subject><ispartof>Missouri medicine, 2011-05, Vol.108 (3), p.187-194</ispartof><rights>Copyright 2011 by the Missouri State Medical Association 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188294/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188294/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21736079$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salacz, Michael E</creatorcontrib><creatorcontrib>Watson, Kenneth R</creatorcontrib><creatorcontrib>Schomas, David A</creatorcontrib><title>Glioblastoma: Part I. Current state of affairs</title><title>Missouri medicine</title><addtitle>Mo Med</addtitle><description>Although uncommon, "brain cancer" is one of the most feared diseases that afflict human beings. While still regarded as one of the most deadly forms of primary brain neoplasm, recent advances in the treatment of glioblastoma (GBM) have offered new hope for patients, families, and clinicians. In the first part of this two-part review, we will focus on the multidisciplinary advances that have established the current treatment approach in the management of GBM. In the second part of this review, ongoing research will be presented including current clinical trials as well as some of the newer technologies that are forming the promise of the future.</description><subject>Additional Scientific</subject><subject>Brain Neoplasms - diagnosis</subject><subject>Brain Neoplasms - mortality</subject><subject>Brain Neoplasms - surgery</subject><subject>Brain Neoplasms - therapy</subject><subject>Chemotherapy, Adjuvant</subject><subject>Clinical Trials as Topic</subject><subject>Combined Modality Therapy - methods</subject><subject>Glioblastoma - diagnosis</subject><subject>Glioblastoma - mortality</subject><subject>Glioblastoma - surgery</subject><subject>Glioblastoma - therapy</subject><subject>Humans</subject><subject>Meta-Analysis as Topic</subject><subject>Neoplasm Staging</subject><subject>Radiotherapy, Adjuvant</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><subject>United States - epidemiology</subject><issn>0026-6620</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkMFKxDAQhnNQ3HX1FaQ3T13SpE1SD4IUXRcW9KDnMG0mGmmbNUkF396Cq-hpfpif7xvmiCwpZSIXgtEFOY3xjVJeK85OyIIVkgsq6yVZb3rn2x5i8gNcZY8QUrZdZ80UAo4piwkSZt5mYC24EM_IsYU-4vlhrsjz3e1Tc5_vHjbb5maX7wtFU67aopVlyxCwK4xBsLLEsq4qZlgtAW1hOKfKdhIp52IOIKm1lTFgLDDFV-T6m7uf2gFNN98SoNf74AYIn9qD0_83o3vVL_5Di0IpVpcz4PIACP59wpj04GKHfQ8j-ilqJSvJaC3E3Lz4q_p1_PyIfwFeYmMa</recordid><startdate>201105</startdate><enddate>201105</enddate><creator>Salacz, Michael E</creator><creator>Watson, Kenneth R</creator><creator>Schomas, David A</creator><general>Journal of the Missouri State Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201105</creationdate><title>Glioblastoma: Part I. Current state of affairs</title><author>Salacz, Michael E ; Watson, Kenneth R ; Schomas, David A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p180t-8b1b74b2eaec1ddeaf74e49552d297aef1d3308fc7e03368fca70ff5ddadfa283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Additional Scientific</topic><topic>Brain Neoplasms - diagnosis</topic><topic>Brain Neoplasms - mortality</topic><topic>Brain Neoplasms - surgery</topic><topic>Brain Neoplasms - therapy</topic><topic>Chemotherapy, Adjuvant</topic><topic>Clinical Trials as Topic</topic><topic>Combined Modality Therapy - methods</topic><topic>Glioblastoma - diagnosis</topic><topic>Glioblastoma - mortality</topic><topic>Glioblastoma - surgery</topic><topic>Glioblastoma - therapy</topic><topic>Humans</topic><topic>Meta-Analysis as Topic</topic><topic>Neoplasm Staging</topic><topic>Radiotherapy, Adjuvant</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salacz, Michael E</creatorcontrib><creatorcontrib>Watson, Kenneth R</creatorcontrib><creatorcontrib>Schomas, David A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Missouri medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salacz, Michael E</au><au>Watson, Kenneth R</au><au>Schomas, David A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glioblastoma: Part I. Current state of affairs</atitle><jtitle>Missouri medicine</jtitle><addtitle>Mo Med</addtitle><date>2011-05</date><risdate>2011</risdate><volume>108</volume><issue>3</issue><spage>187</spage><epage>194</epage><pages>187-194</pages><issn>0026-6620</issn><abstract>Although uncommon, "brain cancer" is one of the most feared diseases that afflict human beings. While still regarded as one of the most deadly forms of primary brain neoplasm, recent advances in the treatment of glioblastoma (GBM) have offered new hope for patients, families, and clinicians. In the first part of this two-part review, we will focus on the multidisciplinary advances that have established the current treatment approach in the management of GBM. In the second part of this review, ongoing research will be presented including current clinical trials as well as some of the newer technologies that are forming the promise of the future.</abstract><cop>United States</cop><pub>Journal of the Missouri State Medical Association</pub><pmid>21736079</pmid><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0026-6620 |
| ispartof | Missouri medicine, 2011-05, Vol.108 (3), p.187-194 |
| issn | 0026-6620 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6188294 |
| source | MEDLINE; PubMed Central |
| subjects | Additional Scientific Brain Neoplasms - diagnosis Brain Neoplasms - mortality Brain Neoplasms - surgery Brain Neoplasms - therapy Chemotherapy, Adjuvant Clinical Trials as Topic Combined Modality Therapy - methods Glioblastoma - diagnosis Glioblastoma - mortality Glioblastoma - surgery Glioblastoma - therapy Humans Meta-Analysis as Topic Neoplasm Staging Radiotherapy, Adjuvant Survival Rate Treatment Outcome United States - epidemiology |
| title | Glioblastoma: Part I. Current state of affairs |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T13%3A45%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glioblastoma:%20Part%20I.%20Current%20state%20of%20affairs&rft.jtitle=Missouri%20medicine&rft.au=Salacz,%20Michael%20E&rft.date=2011-05&rft.volume=108&rft.issue=3&rft.spage=187&rft.epage=194&rft.pages=187-194&rft.issn=0026-6620&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E875720966%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=875720966&rft_id=info:pmid/21736079&rfr_iscdi=true |